Atea Pharmaceuticals, Inc. (AVIR)
4.67
-0.06
(-1.27%)
USD |
NASDAQ |
May 29, 16:00
4.66
-0.01
(-0.21%)
After-Hours: 20:00
Atea Pharmaceuticals Total Assets (Quarterly) : 267.08M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 108.37M |
| CorMedix, Inc. | 815.64M |
| Eloxx Pharmaceuticals, Inc. | 8.503M |
| Cannabis Global, Inc. | 0.885M |
| Breakthrough Chemistry, Inc. | 2.255M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.37M |
| Shareholders Equity (Quarterly) | 233.71M |
| Debt to Equity Ratio | 0.0027 |
| Current Ratio | 7.888 |
| Net Debt Paydown Yield | 0.05% |